Neuroprotective effects of diallyl trisulfide in SOD1-G93A transgenic mouse model of amyotrophic lateral sclerosis

被引:29
作者
Guo, Yansu [1 ,2 ,3 ]
Zhang, Kunxi [1 ]
Wang, Qian [1 ]
Li, Zhongyao [1 ,2 ,3 ]
Yin, Yunxia [1 ]
Xu, Qingmei [1 ]
Duan, Weisong [1 ,2 ,3 ]
Li, Chunyan [1 ,2 ,3 ]
机构
[1] Hebei Med Univ, Dept Neurol, Hosp 2, Shijiazhuang 050000, Hebei Province, Peoples R China
[2] Inst Cardiocerebrovasc Dis, Shijiazhuang 050000, Hebei, Peoples R China
[3] Neurol Lab Hebei Prov, Shijiazhuang 050000, Hebei, Peoples R China
基金
中国国家自然科学基金;
关键词
Amyotrophic lateral sclerosis; Cu/Zn superoxide dismutase; Transgenic mouse; Diallyl trisulfide; Neuroprotection; MOTOR-NEURON DEGENERATION; OXIDATIVE STRESS; HEME OXYGENASE-1; THERAPEUTIC TARGET; MICE; ALS; PATHOGENESIS; INDUCTION; DISEASE; ENZYMES;
D O I
10.1016/j.brainres.2010.12.014
中图分类号
Q189 [神经科学];
学科分类号
071006 [神经生物学];
摘要
Diallyl trisulfide (DAIS) is one of the major constituents in garlic oil and has been documented to transcriptionally activate phase II enzymes. The purpose of this study is to evaluate the effects of DAIS in prolonging disease duration and survival in a transgenic mouse model of amyotrophic lateral sclerosis (ALS). SOD1-G93A transgenic mice were randomly divided into DATS-treated group (80 mg/kg/d, p.o.) and vehicle-treated group at disease onset stage. Oral administration of DATS beginning at clinical onset stage significantly prolonged disease duration and extended life span for about one week. DATS treatment induced HO-1 and reduced GFAP expression in the lumbar spinal cord of SOD1-G93A transgenic mice. This study indicates that DATS has multifunctional neuroprotective effects in SOD1-G93A transgenic mice. (C) 2010 Elsevier B.V. All rights reserved.
引用
收藏
页码:110 / 115
页数:6
相关论文
共 26 条
[1]
Oxidative stress in ALS: Key role in motor neuron injury and therapeutic target [J].
Barber, Sian C. ;
Shaw, Pamela J. .
FREE RADICAL BIOLOGY AND MEDICINE, 2010, 48 (05) :629-641
[2]
Heme oxygenase-1-generated biliverdin ameliorates experimental murine colitis [J].
Berberat, PO ;
A-Rahim, YI ;
Yamashita, K ;
Warny, MM ;
Csizmadia, E ;
Robson, SC ;
Bach, FH .
INFLAMMATORY BOWEL DISEASES, 2005, 11 (04) :350-359
[3]
Neurodegeneration in amyotrophic lateral sclerosis:: the role of oxidative stress and altered homeostasis of metals [J].
Carrì, MT ;
Ferri, A ;
Cozzolino, M ;
Calabrese, L ;
Rotilio, G .
BRAIN RESEARCH BULLETIN, 2003, 61 (04) :365-374
[4]
Induction of detoxifying enzymes by garlic organosulfur compounds through transcription factor Nrf2: Effect of chemical structure and stress signals [J].
Chen, C ;
Pung, D ;
Leong, V ;
Hebbar, V ;
Shen, GX ;
Nair, S ;
Li, W ;
Kong, ANT .
FREE RADICAL BIOLOGY AND MEDICINE, 2004, 37 (10) :1578-1590
[5]
Diagnosis, Pathogenesis and Therapeutic Targets in Amyotrophic Lateral Sclerosis [J].
Costa, Julia ;
Gomes, Catarina ;
de Carvalho, Mamede .
CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS, 2010, 9 (06) :764-778
[6]
The effects of allyl sulfides on the induction of phase II detoxification enzymes and liver injury by carbon tetrachloride. [J].
Fukao, T ;
Hosono, T ;
Misawa, S ;
Seki, T ;
Ariga, T .
FOOD AND CHEMICAL TOXICOLOGY, 2004, 42 (05) :743-749
[7]
Decreased GLT-1 and increased SOD1 and HO-1 expression in astrocytes contribute to lumbar spinal cord vulnerability of SOD1-G93A transgenic mice [J].
Guo, Yansu ;
Duan, Weisong ;
Li, Zhongyao ;
Huang, Jing ;
Yin, Yunxia ;
Zhang, Kunxi ;
Wang, Qian ;
Zhang, Zhifang ;
Li, Chunyan .
FEBS LETTERS, 2010, 584 (08) :1615-1622
[8]
MOTOR-NEURON DEGENERATION IN MICE THAT EXPRESS A HUMAN CU,ZN SUPEROXIDE-DISMUTASE MUTATION [J].
GURNEY, ME ;
PU, HF ;
CHIU, AY ;
DALCANTO, MC ;
POLCHOW, CY ;
ALEXANDER, DD ;
CALIENDO, J ;
HENTATI, A ;
KWON, YW ;
DENG, HX ;
CHEN, WJ ;
ZHAI, P ;
SUFIT, RL ;
SIDDIQUE, T .
SCIENCE, 1994, 264 (5166) :1772-1775
[9]
A role for neurofilaments in the pathogenesis of amyotrophic lateral sclerosis [J].
Julien, JP .
BIOCHEMISTRY AND CELL BIOLOGY-BIOCHIMIE ET BIOLOGIE CELLULAIRE, 1995, 73 (9-10) :593-597
[10]
Treatment with arimoclomol, a coinducer of heat shock proteins, delays disease progression in ALS mice [J].
Kieran, D ;
Kalmar, B ;
Dick, JRT ;
Riddoch-Contreras, J ;
Burnstock, G ;
Greensmith, L .
NATURE MEDICINE, 2004, 10 (04) :402-405